General Information
Drug ID
DR01379
Drug Name
Mequitazine
Synonyms
Butix; Instotal; Kitazemin; Mequitazina; Mequitazinum; Metaplexan; Mircol; Primalan; Quitadrill; Vigigan; Virginan; Zesulan; Italfarmaco brand of mequitazine; Mequitazina [Spanish]; Mequitazine hydrochloride; Pierre Fabre brand of mequitazine; LM 209; Kitazemin (TN); LM-209; Mequitazina [INN-Spanish]; Mequitazinum [INN-Latin]; Mequitazine (JP15/INN); Mequitazine [INN:BAN:DCF:JAN]; Mequitazine tartrate, (R-(R*,R*))-isomer; 10-(1-Azabicyclo[2.2.2]oct-3-ylmethyl)-10H-phenothiazine; 10-(1-azabicyclo(2.2.2)oct-8-ylmethyl)phenothiazine; 10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine; 10-(3-Quinuclidinylmethyl)phenothiazine; 10H-Phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)-(9CI); 3-Methylquinuclidinyl-10-phenothiazine
Drug Type
Small molecular drug
Indication Allergic rhinitis [ICD11: CA08.0] Approved [1]
Therapeutic Class
Antihistamines
Structure
3D MOL 2D MOL
Formula
C20H22N2S
Canonical SMILES
C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53
InChI
InChI=1S/C20H22N2S/c1-3-7-19-17(5-1)22(18-6-2-4-8-20(18)23-19)14-16-13-21-11-9-15(16)10-12-21/h1-8,15-16H,9-14H2
InChIKey
HOKDBMAJZXIPGC-UHFFFAOYSA-N
CAS Number
CAS 29216-28-2
Pharmaceutical Properties Molecular Weight 322.5 Topological Polar Surface Area 31.8
Heavy Atom Count 23 Rotatable Bond Count 2
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 3
XLogP
4.6
PubChem CID
4066
PubChem SID
453325 , 583144 , 7366094 , 7848387 , 8141047 , 8152552 , 10320045 , 10517343 , 11406959 , 14850608 , 16617285 , 26665232 , 29223177 , 46505779 , 48416221 , 50006661 , 53787706 , 56320321 , 57322124 , 57962172 , 78247115 , 81093314 , 85209426 , 87244027 , 92714662 , 103267575 , 103815311 , 104305332 , 104972177 , 117404379 , 124799813 , 124894252 , 125347181 , 126623962 , 126655271 , 126669303 , 128089981 , 131309176 , 134338335 , 134997033 , 137267684 , 140724147 , 142143428 , 144207197 , 160964405 , 163121882 , 164761785 , 164814342 , 170005238 , 170465794
ChEBI ID
CHEBI:31821
TTD Drug ID
D09IMS
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 National Center for Advancing Translational Science-Inxight: drug (Y463242LY2)
2 Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J Pharmacol Exp Ther. 2002 Dec;303(3):1029-37.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.